AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Viatris Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00Y52JV51
18.00▼ 0.48 (-2.60%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
18.48
Day's Range
17.86 – 18.38
52-Week Range
9.92 – 18.75
Volume
7.2M
Avg Volume
8.8M
Share Statistics
Shares Outstanding
Employees
30.0K
Exchange
XNAS
Listed
1973-02-23
Share count as of August 3, 2026

Viatris Inc. Common Stock (VTRS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Viatris Inc. Common Stock (VTRS)
What is Viatris Inc. Common Stock's Market Cap?
Viatris Inc. Common Stock's Market Cap is $20.7B, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's Enterprise Value?
Viatris Inc. Common Stock's Enterprise Value is $33.1B, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's Price / Sales?
Viatris Inc. Common Stock's Price / Sales is 1.4×, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's EV / Revenue?
Viatris Inc. Common Stock's EV / Revenue is 2.3×, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's EV / EBITDA?
Viatris Inc. Common Stock's EV / EBITDA is 12.2×, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's Revenue (TTM)?
Viatris Inc. Common Stock's Revenue (TTM) is $14.7B, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's Net Income (TTM)?
Viatris Inc. Common Stock's Net Income (TTM) is -$3.5B, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's EBITDA?
Viatris Inc. Common Stock's EBITDA is $2.7B, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's Diluted EPS (TTM)?
Viatris Inc. Common Stock's Diluted EPS (TTM) is -3.06, based on as-reported figures from SEC (XBRL) filings.
What is Viatris Inc. Common Stock's EBITDA Margin?
Viatris Inc. Common Stock's EBITDA Margin is 18.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · VTRSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth+5.0%+8.2%+5.0%+0.3%
Other revenues
Total revenues
Cost of sales
Gross profit
% of revenue38.9%33.0%31.1%36.6%
Operating expenses:
Research and development
Acquired IPR&D
Selling, general and administrative
Impairment of goodwill
Litigation settlements and other contingencies, net
Total operating expenses
% of revenue38.7%35.2%36.3%31.8%
Earnings (loss) from operations
% of revenue0.2%-2.3%-5.2%4.8%
Interest expense
Other (income) expense, net
Loss before income taxes
Income tax provision (benefit)
Net (loss) earnings
(Loss) earnings per share attributable to Viatris Inc. shareholders
Basic (in USD per share)—
Diluted (in USD per share)—